3Yamashite T,Kawashima S, Ozaki M, et al. A calcium channel blocker benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production [J]. J Hypertens, 2001,19(6) :451-458.
1Boden WE,O'Rourke RA,Ten KK,et al.Optimal medical therapy with or without PCI for stable coronary disease[J].N Engl J Med,2007,15(356):1503-1515.
2Smith SC Jr,Fdldman TE,Hirshfeld JW Jr,et al.ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAL Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)[J].J Am Coll Cardiol,2006,47(1):216-235.
3Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies[J].Circulation,2003,108(15):1664-1672.
4Cannon CP,Braunwald E,McCabe CH,et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350(15):1495-1504.
5Pitt B,Waters D,Brown W,et al.Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease[J].N Engl J Med,1999,341(2):70-76.
6Katritsis DG,Loannidis JP.Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease:a meta-analysis[J].Circulation,2005,111(22):2906-2912.
7Lagakos SW.The challenge of subgroup analyses-reporting without distorting[J].N Engl J Med,2006,354(16):1667-1669.
8Fox K,Garcia MA,Ardissino D,et al.Guidelines on the management of stable angina pectoris:executive summary:the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology[J].Eur Heart J,2006,27(11):1341-13481.
